Cargando…
T-cell lymphomas, a challenging disease: types, treatments, and future
T-cell lymphomas are rare and aggressive malignancies associated with poor outcome, often because of the development of resistance in the lymphoma against chemotherapy as well as intolerance in patients to the established and toxic chemotherapy regimens. In this review article, we discuss the epidem...
Autores principales: | Ma, Helen, Abdul-Hay, Maher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102240/ https://www.ncbi.nlm.nih.gov/pubmed/27743148 http://dx.doi.org/10.1007/s10147-016-1045-2 |
Ejemplares similares
-
Novel agents in the treatment of multiple myeloma: a review about the future
por: Naymagon, Leonard, et al.
Publicado: (2016) -
Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
por: Cytryn, Samuel, et al.
Publicado: (2020) -
Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions
por: Lees, Charlotte, et al.
Publicado: (2019) -
Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults
por: Tegla, Cosmin, et al.
Publicado: (2020) -
A Challenging Blastic Plasmacytoid Dendritic Cell Neoplasm Case: Tough Decisions to Make
por: Han, Joseph, et al.
Publicado: (2018)